Slower tumour growth correlated with a slightly increased presence of CD8+ T cells in tumours of both vaccinated cohorts, which, however, did not reach the significantly higher levels seen in the OVA-vaccinated mice (Supplementary Fig. 9A). Here, CD8A is linked to neoplasm.